Years Later, MS Drug Ownership Consolidation — M&A Next?
By:
DailyFinance.com
DailyFinance.com : Biogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes "better late than never." The biotech and drug company is the leader in multiple sclerosis treatment, and it has finally decided to take full ... Read more
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here